Latest Insider Transactions at Athenex, Inc. (ATNX)
This section provides a real-time view of insider transactions for Athenex, Inc. (ATNX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Athenex, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Athenex, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 05
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
8,382
+3.24%
|
$8,382
$1.36 P/Share
|
|
May 05
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
368
+8.16%
|
$368
$1.36 P/Share
|
|
May 05
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,603
+6.74%
|
$3,603
$1.36 P/Share
|
|
Apr 21
2023
|
John Vierling Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,513
+34.57%
|
$6,513
$1.3 P/Share
|
|
Apr 21
2023
|
Jinn Wu Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,513
+15.76%
|
$6,513
$1.3 P/Share
|
|
Apr 21
2023
|
Robert J. Spiegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+33.37%
|
$2,300
$1.3 P/Share
|
|
Apr 21
2023
|
Benson Kwan Hung Tsang Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,813
+34.25%
|
$8,813
$1.3 P/Share
|
|
Apr 21
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
8,736
+3.48%
|
$8,736
$1.3 P/Share
|
|
Apr 21
2023
|
Manson Fok Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,747
+4.94%
|
$5,747
$1.3 P/Share
|
|
Apr 21
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,755
+7.51%
|
$3,755
$1.3 P/Share
|
|
Apr 21
2023
|
Stephanie A Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,642
+31.24%
|
$3,642
$1.3 P/Share
|
|
Apr 21
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
383
+9.22%
|
$383
$1.3 P/Share
|
|
Apr 07
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
410
+10.79%
|
$410
$1.22 P/Share
|
|
Apr 07
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
9,344
+3.85%
|
$9,344
$1.22 P/Share
|
|
Apr 07
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,017
+8.64%
|
$4,017
$1.22 P/Share
|
|
Mar 24
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,525
+8.4%
|
$3,525
$1.39 P/Share
|
|
Mar 24
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
360
+10.78%
|
$360
$1.39 P/Share
|
|
Mar 24
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
8,201
+3.53%
|
$8,201
$1.39 P/Share
|
|
Mar 10
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
258
+8.97%
|
$258
$1.94 P/Share
|
|
Mar 10
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,526
+6.75%
|
$2,526
$1.94 P/Share
|
|
Mar 10
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
5,519
+2.49%
|
$5,519
$1.94 P/Share
|
|
Feb 24
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
1,591
+0.75%
|
$3,182
$2.74 P/Share
|
|
Feb 24
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,788
+5.23%
|
$3,576
$2.74 P/Share
|
|
Feb 24
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
182
+7.16%
|
$364
$2.74 P/Share
|
|
Feb 22
2023
|
Joe Annoni Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
250
-40.0%
|
$500
$2.66 P/Share
|
|
Feb 22
2023
|
Joe Annoni Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
625
+50.0%
|
-
|
|
Feb 10
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,778
+3.44%
|
$0
$0.22 P/Share
|
|
Feb 10
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,222
+4.85%
|
$0
$0.22 P/Share
|
|
Feb 10
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
19,378
+0.46%
|
$0
$0.22 P/Share
|
|
Jan 27
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,584
+5.88%
|
$0
$0.19 P/Share
|
|
Jan 27
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,323
+4.11%
|
$0
$0.19 P/Share
|
|
Jan 27
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
22,533
+0.54%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Manson Fok Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,323
+1.89%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
John Vierling Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,701
+28.21%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Robert J. Spiegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,130
+26.03%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Jinn Wu Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,701
+7.47%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Stephanie A Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,538
+22.6%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Benson Kwan Hung Tsang Director |
BUY
Grant, award, or other acquisition
|
Direct |
61,831
+27.61%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,688
+6.48%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,344
+4.46%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
23,441
+0.56%
|
$0
$0.19 P/Share
|
|
Dec 30
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
77,288
+1.85%
|
$0
$0.15 P/Share
|
|
Dec 30
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,220
+5.81%
|
$0
$0.15 P/Share
|
|
Dec 30
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,390
+8.59%
|
$0
$0.15 P/Share
|
|
Dec 16
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,223
+11.44%
|
$0
$0.12 P/Share
|
|
Dec 16
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,386
+7.57%
|
$0
$0.12 P/Share
|
|
Dec 16
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
96,284
+2.33%
|
$0
$0.12 P/Share
|
|
Dec 02
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
57,287
+1.44%
|
$0
$0.2 P/Share
|
|
Dec 02
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,623
+5.04%
|
$0
$0.2 P/Share
|
|
Dec 02
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,512
+8.11%
|
$0
$0.2 P/Share
|